Schroder Adveq

Schroder Adveq is a leading asset manager investing in private equity globally.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Industries / Tags:

Detailed Schroder Adveq Information

Geographic Data

Schroder Adveq headquarters map

Address: Affolternstrasse 56

City: Zurich

State: zurich

Zip: CH-8050

Country: CH

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Schroder Adveq was founded in 1997 and is a leading asset manager investing globally in private equity. Pension funds, insurance companies, endowments, family offices and other financial institutions located in Europe, North America and the Asia-Pacific region entrust us with their funds because of our solution-focused approach to private equity.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
7/2020 MISSION Therapeutics Venture Round 15M
8/2021 LEAP India Secondary Market 34M
1/2020 iOnctura Series A 16.6M
6/2021 Alentis Therapeutics Series B 66.8M
7/2018 Pliant Therapeutics Series B 0
11/2020 Memo Therapeutics Series B 15.6M
7/2019 Revolution Medicines Series C 100M
12/2019 ImmunOs Therapeutics Series A 0
7/2018 Nohla Therapeutics Series B 11M
8/2019 Araris Biotech Seed Round 2.6M
10/2020 Araris Biotech Seed Round 0
10/2018 ImmunOs Therapeutics Venture Round -
7/2020 iOnctura Series A 5.8M
9/2020 Casma Therapeutics Series B 50M
6/2022 Lenskart Series I 0
6/2020 Goldfinch Biopharma Series B 100M
5/2021 Tessian Series C 65M
11/2020 Synendos Therapeutics Series A 0
6/2018 Decibel Therapeutics Series C 55M
5/2021 HAYA Therapeutics SA Seed Round 18M
2/2022 HAYA Therapeutics Seed Round 0
5/2021 HAYA Therapeutics Seed Round 0
3/2019 IfChange Series C 80M
4/2019 Alentis Therapeutics Series A 12.3M
6/2022 ImmunOs Therapeutics Series B 0
5/2018 Memo Therapeutics Series A 5M
9/2017 Amal Therapeutics Series B 9.5M
11/2018 Amal Therapeutics Series B 32.6M
4/2018 Revolution Medicines Series B 56M
10/2020 Cedilla Therapeutics Series B 57.6M
3/2020 Pliant Therapeutics Series C 0
4/2021 Bizongo Series C 0
1/2020 Bizongo Series C 30M
6/2022 Lenskart Series I 0
6/2022 ImmunOs Therapeutics Series B 0
2/2022 HAYA Therapeutics Seed Round 0
8/2021 LEAP India Secondary Market 0
6/2021 Alentis Therapeutics Series B 0
5/2021 Tessian Series C 0
5/2021 HAYA Therapeutics Seed Round 0
4/2021 Bizongo Series C 0
11/2020 Synendos Therapeutics Series A 0
11/2020 Memo Therapeutics Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research